CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers

OBJECTIVES: Pantoprazole is metabolized by cytochrome P450 2 C19, which shows genetic polymorphism. The effect of CYP2C19 polymorphism on single-dose pharmacokinetics of oral pantoprazole in healthy volunteers was evaluated. METHODS: Pantoprazole pharmacokinetics was determined in 32 healthy volunte...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawrońska-Szklarz, Barbara, Adamiak-Giera, Urszula, Wyska, Elżbieta, Kurzawski, Mateusz, Gornik, Wanda, Kaldonska, Maria, Drozdzik, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Pharmacogenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419350/
https://www.ncbi.nlm.nih.gov/pubmed/22418828
http://dx.doi.org/10.1007/s00228-012-1252-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419350/
https://www.ncbi.nlm.nih.gov/pubmed/22418828
http://dx.doi.org/10.1007/s00228-012-1252-3

Ejemplares similares